CRBP
NASDAQ · Biotechnology
Corbus Pharmaceuticals Holdi
$7.83
+0.44 (+5.95%)
Open$7.53
Previous Close$7.39
Day High$7.89
Day Low$7.41
52W High$14.86
52W Low$7.95
Volume—
Avg Volume413.5K
Market Cap137.44M
P/E Ratio—
EPS$-1.76
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+55.2% upside
Current
$7.83
$7.83
Target
$12.15
$12.15
$8.71
$12.15 avg
$17.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 72.40M | 73.75M | 70.02M |
| Net Income | -2,537,554 | -2,715,843 | -3,439,667 |
| Profit Margin | -3.5% | -3.7% | -4.9% |
| EBITDA | -3,891,696 | -4,515,140 | -4,413,459 |
| Free Cash Flow | -4,239,895 | -2,837,667 | -3,192,005 |
| Rev Growth | +4.2% | -7.8% | -7.0% |
| Debt/Equity | 0.37 | 0.31 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |